MAPK3 and gastric cancer: The expression of TRPC1/3 was upregulated in GC cells in response to the TGF-β1-induced EMT, and blockade of TRPC1/3 channels with nonspecific pharmacological inhibitors attenuated EMT progression by suppressing the Ras/Raf1/ERK1/2 signaling pathway [88].